Corporate Profile

At Talis, we strive to deliver excellence in point of care diagnostics by increasing access to timely and accurate testing that can help combat the spread of known and emerging infectious diseases.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases

22 Mar '23
Talis Announces Fourth Quarter and Full Year 2022 Financial Results
REDWOOD CITY, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today reported

View More

Recent Events

View More

Executive Team

Rob Kelley

Rob Kelley

Chief Executive Officer

Roger Moody, M.B.A.

Becky Markovich

Interim Chief Financial Officer

Emily Faucette photo

Emily Faucette

Senior Vice President, Communications & IR

View More